A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)
Clinical trial NCT06101095 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06101095
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-29
- Primary completion
- 2025-11-05
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.